Hear from three female senior leaders as they offer perspectives on our commitment to gender equality.
Hear from Craig Hopkinson, M.D. as he reflects on the unmet needs of people living with narcolepsy.
This year, we’re celebrating 15 years of “Alkermes in Action,” our employee-led volunteer program that supports local non-profit organizations through hands-on activities.
Throughout June, Team Alkermes celebrated Pride Month with events hosted by Pride@Work, our ERG for LGBTQ+ employees and allies.
See what our valued co-leaders have to say about our ERG for LGBTQ+ employees and allies.
We’re proud to recognize Swetha Krishnan, Senior Director of Quality, as our 2023 Healthcare Businesswomen’s Association (HBA) Rising Star – a testament to her leadership and commitment to excellence.
Hear from Steve Schiavo on Alkermes' commitment to being a recovery-friendly workplace.
Hear from Markus Haeberlein, Ph.D. where he discusses our commitment to researching potential treatment options for people living with sleep disorders.
This Women’s History Month, we celebrate the accomplishments of the many women making a difference at Alkermes. Meet the co-leads of Mosaic, our ERG dedicated to multicultural diversity.
Hear from Dr. Craig Hopkinson in this PharmaVoice article where he discusses our commitment to developing novel potential therapies for people living with difficult-to-treat cancers.
Hear from leaders of Operation Salute, our ERG dedicated to recognizing and supporting veterans and their family members.
Hear from leaders of Limitless, our ERG dedicated to empowering those whose lives are impacted by disability or illness.
Alkermes worked with The Harris Poll to gather psychiatrists’ insights and perspectives on caring for people living with bipolar I disorder.
Congratulations to Kanchan Relwani, M.D., Head of Medical Affairs, for being recognized as our 2022 Healthcare Businesswomen’s Association Luminary – a testament to her role as a mentor and leader.
Learn more about our ongoing clinical development program for nemvaleukin alfa, our lead immuno-oncology candidate.
Alkermes' Head of Human Resources Steve Schiavo reflects on our employees' commitment during the COVID-19 pandemic.
As the unmet medical need in oncology changes, Alkermes is using its R&D capabilities honed over 30 years of work on complex diseases to investigate a potential next breakthrough in cancer therapy.
Alkermes employees seek to make a positive impact in their communities by taking part in Alkermes in Action, our employee-led volunteer program that represents our commitment to giving back to our loc
Alkermes worked with The Harris Poll to conduct a survey exploring drinking patterns during the COVID-19 pandemic and people’s motivations to seek help.
In a recent interview with Informa Connect's Xconomy, our Chief Operating Officer, Blair Jackson, discusses our ambitions and our evolving strategy in neuroscience and oncology.
We hosted a webcast in June 2021 with expert oncologists and ARTISTRY clinical program investigators to review data updates presented at the 2021 ASCO Annual Meeting.
We’re proud to recognize Joyanna Wesche-Blake, Senior Director of IT, as our 2021 Healthcare Businesswomen’s Association (HBA) Rising Star – a testament to her leadership and commitment to excellence.
We hosted a virtual Investor Day in March 2021 to discuss our research and development strategy and portfolio, including updates from our nemvaleukin alfa development program in immuno-oncology and ne
In this “The Medicine Maker” article, our Chief Operating Officer, Blair Jackson, discusses how to determine corporate readiness when exploring a new therapeutic area and reflects on Alkermes' entry i